It was announced on Vcanbio Cell & Gene Engineering Corp.Ltd(600645) 14 that the controlling shareholder Deyuan investment irrevocably authorized Jiadao Chenggong as the sole and exclusive agent of its 32.72 million shares of the company (accounting for 6.99% of the total share capital).
After the entrustment of voting rights is completed, the total number of shares with voting rights held by Jiadao Chenggong and its persons acting in concert in the company accounts for 17.83% of the total shares of the company. Jiadao has successfully become the controlling shareholder of the company, and Chen Chunmei and Gong Hongjia have jointly become the actual controllers of the company.
This means that the era of Li Defu officially ends and Vcanbio Cell & Gene Engineering Corp.Ltd(600645) enters the era of Gong Hongjia.
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) change of controlling shareholder
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) announced that Vcanbio Cell & Gene Engineering Corp.Ltd(600645) received the notice from the controlling shareholder Deyuan investment, and Deyuan investment successfully signed the voting right entrustment agreement with Jiadao on December 14, 2021. Deyuan investment irrevocably authorized Jiadao success as the sole and exclusive agent of the company’s 327232.6 million shares (accounting for 6.99% of the total share capital), The voting rights corresponding to the above equity are irrevocably entrusted to Jiadao for successful exercise. Deyuan investment has pledged the above shares to Jiadao on April 28, 2021 for financing guarantee.
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) indicates that this entrustment starts from the effective date of the agreement to the date of termination of the agreement, and terminates when one of the following events occurs: (1) both parties decide to terminate the agreement by consensus; (2) Deyuan investment transferred all the entrusted shares to Jiadao success; (3) If Deyuan investment loses the ownership of all entrusted shares and Jiadao successfully requests to terminate the agreement; (4) If Deyuan investment violates laws, regulations and commitments, violates the agreement and damages the interests of the listed company or jiadaogong, jiadaogong requests to terminate the agreement.
Prior to the entrustment of voting rights, Deyuan investment and Li Defu jointly held 57607119 shares of the company, accounting for 12.31% of the total shares of the company. Deyuan investment was the controlling shareholder of the company and Li Defu was the actual controller of the company. Mr. Li Defu resigned as vice chairman, director and member of the Strategy Committee on January 21, 2021. After his resignation, he will no longer hold other positions in the company.
The announcement pointed out that after this voting entrustment, Jiadao successfully directly held 44943820 shares of the company and obtained 32723260 shares of the entrusted voting company. Its concerted actor, Beijing Yinhong Chunhui Investment Management Co., Ltd. (hereinafter referred to as “Yinhong Chunhui”) held 5761349 shares of the company, with a total of 83428429 shares of the company’s voting rights, Accounting for 17.83% of the total shares of the company, Jiadao has successfully become the controlling shareholder of the company.
According to the announcement, Chen Chunmei and Gong Hongjia are the actual controllers of Jiadao. Therefore, Chen Chunmei and Gong Hongjia jointly become the actual controllers of the company.
After the change of actual controller, Vcanbio Cell & Gene Engineering Corp.Ltd(600645) ‘s control right structure is as follows:
Vcanbio Cell & Gene Engineering Corp.Ltd(600645) is a life science and technology innovation enterprise focusing on the development of “precision medicine”. Focusing on the three subdivided fields of “precision prevention”, “precision diagnosis” and “precision treatment”, the company’s main business covers the whole industrial chain, such as cell storage, gene testing, new drug research and development, and the research, production and marketing of in vitro diagnostic reagents, genes, proteins and antibodies. The company has advanced cell technology and national cell resource storage network, and the cell storage capacity has exceeded 300000 copies. It is one of the important national cell technology product R & D and transformation bases.
According to the third quarterly report of 2021, the main revenue of Vcanbio Cell & Gene Engineering Corp.Ltd(600645) in the first three quarters was 1.16 billion yuan, a year-on-year increase of 19.64%; The net profit attributable to the parent company was 191 million yuan, a year-on-year increase of 43.36%.
Gong Hongjia also served as chairman of 4 companies and director of 14 companies
Gong Hongjia is both an entrepreneur and an investor on many occasions. In the early stage, he went south to Shenzhen to work to establish Desheng company, the first brand of Chinese radio, and earned the first pot of gold in his life; The establishment of Zhejiang Dekang communication was merged by CICA and landed on Nasdaq, realizing the first exit project in life, and then investing in Hangzhou Hikvision Digital Technology Co.Ltd(002415) , Shanghai Fullhan Microelectronics Co.Ltd(300613) electronics, making tens of thousands of times and thousands of times.
Born in 1965, he graduated from Huazhong University of science and technology. What he liked and was good at was liberal arts. He dreamed of being a reporter and a lawyer. He also got the only full score of composition in the province during the college entrance examination. However, he finally applied to Huazhong Institute of Technology (Huazhong University of science and Technology) to study computer and has “four major engineering colleges”, “four electrical tigers” Chinese workers with titles such as “eight medical schools” have gathered a group of the best men of science and technology in China, and these resources have become his “investment chassis” in the future, including Hangzhou Hikvision Digital Technology Co.Ltd(002415) founders Chen zongnian and Hu Yangzhong.
Talking about Gong Hongjia, the most difficult thing is Hangzhou Hikvision Digital Technology Co.Ltd(002415) . In 2001, he invested 2.45 million in Hangzhou Hikvision Digital Technology Co.Ltd(002415) . So far, as the second largest shareholder of Hangzhou Hikvision Digital Technology Co.Ltd(002415) , Gong Hongjia holds 963 million shares, accounting for 10.31% of the total share capital, with a market value of more than 50 billion yuan.
Since the third quarter of last year, Gong Hongjia has reduced Hangzhou Hikvision Digital Technology Co.Ltd(002415) for three consecutive quarters. Based on the quarterly average price of holdings reduction, the cash amount of its portfolio exceeded 13 billion.
Last year, he received an exclusive interview with a reporter from the securities times as the founder of Jiadao capital. When it comes to how to invest in excellent enterprises, Gong Hongjia is modest, saying that each successful enterprise invested has nothing to do with their own efforts, but has a lot to do with the efforts, talents, sense of mission and Entrepreneurship of the founders and managers.
“What I want to do is to encourage them when they feel hesitant and uncertain, and push them when they are in trouble. If we can find people with the above characteristics and abilities, responsibility and sense of mission in each industry, we may become the most successful company in that industry.” He told reporters during the interview.
According to the official website of Vcanbio Cell & Gene Engineering Corp.Ltd(600645) , Gong Hongjia is also the chairman of Hangzhou Fuxin Zhangjing Technology Co., Ltd., Beijing Funian Technology Co., Ltd., Sichuan Jiadao Bowen Ecological Technology Co., Ltd. and Shanghai Aoyuan medical supplies Co., Ltd. In addition, Gong Hongjia is also the chairman of the board of directors of Funian Technology Co., Ltd.
Gong Hongjia also serves as a director of 14 companies, including Furong Technology Co., Ltd. Shanghai Fullhan Microelectronics Co.Ltd(300613) , Shenzhen innovation Valley Investment Management Co., Ltd., Shanghai pukun Information Technology Co., Ltd., fuce Holdings Co., Ltd., Chuangjia Venture Capital Co., Ltd., 981 Health Science and Technology Group Co., Ltd., Beijing jiabowen Biotechnology Co., Ltd Wuhan Youxin Technology Co., Ltd., Qingke Management Consulting Group Co., Ltd., Shenzhen Zhongke scientific and technological achievements transformation Equity Investment Fund Management Co., Ltd., Sichuan Huiyang life Engineering Co., Ltd., Shenzhen xishima Data Technology Co., Ltd. and Beijing nutshell universe Education Technology Co., Ltd.
Gong Hongjia also appointed representatives as executive partners in three enterprises, namely Shenzhen Jiadao Gongcheng equity investment fund (limited partnership), Shenzhen Jiadao Fangzhi education industry investment enterprise (limited partnership) and Shenzhen Jiadao success investment enterprise (limited partnership).
(Securities Times)
